Abstract-Nltnc oxide (NO) plays an important role not only m the regulation of blood vessel tone, but also m the growth of vascular smooth muscle cells (VSMC) The precise mechamsm involved m the mhlbltlon of VSMC growth by NO 1s not known To further explore the effect of NO on VSMC growth, we examined the effect of NO on the expression of anglotensm II type 1 receptor (AT,-R) that Key Words: vascular smooth muscle cells n anglotensm II receptor w NO w gene transcnptlon P rohferatlon of vascular smooth muscle cells (VSMC) contnbutes to pathological changes of vascular wall such as vascular remodeling, medial hyperplasla, and neomtlmal formation associated with hypertension, atherosclerosis, and vascular qury ' In addition, VSMC produce matrix component of vascular wall such as collagen, fibronectm, and growth factors such as platelet-denved growth factor (PDGF) The matnx and growth factors also play important roles m the process of vascular remodehng and atherogenesls Therefore, understanding the mechanism of VSMC prohferatlon 1s of great mterest m vascular biology and chmcal mvestlgatlon Nltnc oxide (NO) 1s produced by a vanety of mammahan cells such as endothehum, neuron, macrophages, and VSMC fi-om L-arguune by NO synthase (NOS) *J Release of NO stimulates soluble guanylyl cyclase, lea&ng to an increase of intracellular cychc guanosine monophosphate (cGMP) level NO dilates blood vessel and inhibits prohferatlon of VSMC and platelet aggregation 3 These propemes are anti-atherogemc, and decreased NOS actnq 1s beheved to be one of the important feature of early atherogemc process ' Supplementahon of L-argmme, the precursor of NO, lessens the extent of atherosclerosis in diet-induced hypercholesterolermc rabbit 4 In vlvo transfer of type III NOS gene Into the balloon-injured artery decreased neolntlmal VSMC prohferahon 5 However, the precise mechamsm of antl-atherogemc property of NO 1s not completely understood Anglotensm (Ang) II 1s an important vasoactlve peptlde and regulates blood pressure, fluld homeostasls, and electrolyte balance by vasoconstnctlon, faclhtatlon of adrenergc nerve actlvlty, and secretion of aldosterone from the adrenal gland " Recent studies have shown that Ang II IS a growth factor of VSMC and endothehum and plays an important role m atherosclerosis The physlologcal function of Ang II IS transmitted mto target cells via its specific receptor located m the cell membrane There are two lsoforrns for Ang II receptor, which are designated as type 1 receptor (AT,-R)" and type 2 receptor (AT,-R) '" " Losartan that binds to AT,-R and PD123319 that binds to AT*-R are considered to be lsoform speclfk antagonist Although emergmg evidences suggest that AT,-R also plays an important role m the regulation of blood pressure,12 growth mhlbltlon," and apoptosa,'4 most of the cardiovascular effects of Ang II has been believed to be medlated by AT,-R"
Abstract-Nltnc oxide (NO) plays an important role not only m the regulation of blood vessel tone, but also m the growth of vascular smooth muscle cells (VSMC) The precise mechamsm involved m the mhlbltlon of VSMC growth by NO 1s not known To further explore the effect of NO on VSMC growth, we examined the effect of NO on the expression of anglotensm II type 1 receptor (AT,-R) that 1s important for hypertrophy and hyperplasla of VSMC S-mtroso acetyl DL-pemclllamme (SNAP, 200pmol/L), a potent NO donor, suppressed expression level of AT,-R mRNA by 90% and AT1-R number by 60% after 24 hours of stlmulatlon
The suppressive effect was dose-dependent Actmomycm D, which 1s an mhlbltor of gene transcnptlon, did not affect the decrease of AT,-R mRNA by NO Cychc guanosme monophosphate (cGMP) analogue, 8 bromo-cGMP, did not affect AT,-R mRNA level Deletion mutants of the promoter region of rat AT,a-R gene were fused to luclferase reporter gene and introduced to VSMC Transfected cells were stimulated with SNAP, and luclferase actlvq was measured Inhibitory effect of NO was still observed m the shortest deletion mutant that contained 61 bp upstream from transcrlptlon start site In this DNA segment, two DNA bmdmg protein were observed by gel moblhty shift assay, and one of these bmdmg proteins was decreased on stlmulatlon by NO NO downregulates AT,-R gene expression independently of cGMP A DNA bmdmg protem that bmds to the proximal promoter region of AT,-R gene may be responsible for this mhlbltory effect The mhlbltlon of ATI-R gene expression may be implicated m the anti-atherogemc property of NO (Hypertension. 1998; 31[part 2] :342-348.)
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In rodents, two subtypes of AT, receptor are cloned and named AT,a and AT,b I5 Cultured VSMC express only AT,a-R, and Ang II induces PDGF-A chain, transformmg growth factor-p and collagen synthesis m cultured VSMC via this receptor These products from VSMC are important for remodeling of vascular wall and progression of atherosclerosis Several reports have shown that NO modulates blologcal function of Ang II such as Ang II-induced migration of VSMC16 or Ang II-mduced cardiac fibross " We have also reported that chrome mhlblhon of rntnc oxide synthesis by N"-mtro Largmme methyl ester (L-NAME) activates the remn-angotensm system and causes vascular remodehng of coronary artenes of the heart " However, It has not been determmed whether NO acts the expression of Ang II receptor In this study, we exammed the effect of NO donor on the expression of AT,-R m cultured VSMC We found that downregulatlon of AT,-R occurs at the transcnptlon level, mdependent of cGMP Reporter gene analyst usmg firefly luclferase gene sugested that proxunal promoter regon of AT,a-R gene was important for this suppressive effect of NO, and a DNA bmdmg protem bound to this segment was decreased by NO treatment These data suggest that blologcal effect of Ang II via AT,-R 1s enhanced when NO achvlty 1s decreased Downregulation of AT,-R may be one of the nnportant mechamsms of the antiatherogemc property of NO region of rat AT,a gene were prepared and fused to luclferase reporter gene as shown m Fig 6A. These AT,-R promoterluclferase fusion DNA constructs were introduced to VSMC. After 48 hours of transfection, SNAP (200 pmol/L) was added, and the VSMC were cultured for additional 24 hours. Luclferase activity of each construct, which 1s normalized by P-galactosldase activity obtained by cotransfected pSV2LacZ, 1s shown in Fig 6B. Successive deletion of the promoter region showed slgmficant decrease of normalized luclferase activity. The suppressive effect of SNAP on the AT,-R gene promoter actlvlty was, however, observed m the shortest deletion mutant (No. 5) that contains 61 bp upstream from transcription start site. Therefore, we assumed that the DNA segment between -61 bp and f25 bp 1s responsible for the suppression of AT,-R gene promoter activity by NO.
Suppression of DNA Binding Protein by SNAP
Next we examined DNA binding proteins that bound to the DNA segment between -61 bp and +25 bp. Gel mobility shift assay using nuclear extracts from unstimulated VSMC showed two DNA binding proteins bound to this DNA segment (Fig 7, lane 1, arrows 1 and 2) . Speclficlty of the bindmg 1s confirmed by adding 50 times molar excess of nonlabeled probe that eliminates these two bands (lane 2). When nuclear extracts from SNAP-stunulated VSMC were used, one DNA bmdmg protem (arrow 2) could not be observed. Therefore, lack of this DNA bmdmg protein m SNAP-stimulated cells may account for the downregulatlon of AT,-R gene expression by NO.
Discussion
In this study, we have demonstrated that NO donor downregulates AT,-R gene expression of VSMC. The effect of NO on the suppression ofAT,-R gene expression is independent of cGMP. We have also shown that proximal promoter region of AT,a-R gene and one of two DNA binding protein bound to this proximal promoter region may be responsible for this suppressive effect of NO on AT,-R gene expression.
NO inhibits growth of VSMC2" It is possible that AT,-R gene is nonspecifically downregulated as general inhibition of VSMC metabolism by NO. However, the inhibitory effect of NO (or NO donor) on the ATT-R-gene expression is not nonspecific because the expression level of actin mRNA was hardly affected by SNAP. NO donor also inhibits Ang IIinduced migration of VSMC." This effect was mimicked by a membrane-permeable cGMP analogue, 8 Br-cGMP. The inhibitory effect of NO on VSMC growth is also cGMP dependent. Our results showed that the suppressive effect of NO on AT,-R gene expression is independent of cGMP. Therefore, the signaling pathway of antimigratory and growthinhibitory effect of NO is different from that of downregulation of AT,-R gene expression. Yu et al*' reported that cGMP-elevating agents such as NO donor inhibit ras-dependent activation of raf-I in epidermal growth factor-stimulated VSMC. Other pathways that may be independent of raf-1 may play a role in the downregulation of AT,-R gene expression. that these two nuclear proteins bmd to the upstream region of the proximal promoter of AT,-R gene, and characterlzatlon of these proteins is m progress.
Little 1~ known about the regulation of gene transcription by NO. Pllz et a13" showed that NO activates gene transcription m fibroblasts via the AP-1 consensus element that fos and Jun heterodnneric DNA bmdmg protein binds. This effect 1s mimicked by 8Br-cGMP, a result 3uggestmg that NO-AP-1 pathway depends on guanylyl cyclaze. Therefore, it 1s unlikely that activation of AP-1 cause? NO-Induced downregulation of AT,-R gene expression that 1s independent of cGMP pathway. Tabuchl et al " reported NO-induced attenuation of AP-1 activity, which iq important for neuronal cell death. AP-1 DNA bmdmg activity was do$e-dependently suppressed by NO donor. However, for mRNA level remamed constant, suggesting that AP-1 bmdmg activity IS povttranscrlptlonally attenuated by NO. These two contradictory results suggest that NO may elicit different effect on AP-1 DNA bmdmg activity depending on cell type. An AP-1 comensus element is found m the promoter region of AT,a-R gene up to 980 bp upstream fi-om the transcription mitlatlon site (Fig 6A) . However, the proximal promoter region of AT,-R gene (-61/ $25) lack? this consensus sequence. Therefore, AP-1 may be n-relevant to NO-induced downregulatlon of AT,-R gene expression m this DNA segment. NO 15 also reported to decrease NF-Kb-hke DNA binding activity that 1~ induced by cytokme stlmulatlon such as mterleukin-1 or tumor necrosis factor (TNF) cy. Inhlbltlon of vascular cell adhesion molecule (VCAM)-1 gene expression m endothehal cell? induced by TNF a correlated well with thk downregulatlon of NF-Kblike DNA binding activity.3" The authors speculated that downregulation NF-Kb DNA binding activity by NO is responsible for the inhibition of TNFol-mediated VCAM-I gene activation. Although the NF-Kb-like sequence is also present in the upstream region of AT,a-R gene promoter, there is no NF-Kb-like sequence in the proximal promoter region.
As seen in the Fig 68, successive deletion of the promoter region of AT,a-R gene reduced the luciferase activity except for the deletion of the DNA segment between -755 bp and -331 bp that enhanced the luciferase activity. In all these constructs, SNAP also suppressed luciferase activity. Because the difference in the reduction rate of relative luciferase activity by SNAP among these constructs is not statistically significant (Fig 6C) , we speculated that the proximal promoter region is important for SNAP-induced downregulation of AT,-R gene expression. However, we have not excluded the possibility that the upstream promoter region also plays a role for the downregulation of AT,-R gene by NO. In particular, the role of AP-1 and NF-KB in NO-induced downregulation of AT, gene will be evaluated in future study.
In this study, we have shown a molecular basis for the downregulation of AT,-R gene expression by NO. In particular, we have found that the proximal promoter region of AT,-R gene is important for the downregulation by NO and that one DNA binding protein is missed when VSMC is stimulated with SNAP. Characterization of this NO-suppressible DNA binding protein and evaluation of the role of cis DNA elements whose activity is modulated by NO in the upstream region of the AT,-R gene promoter will be necessary for further understanding of the mechanism. The results shown here are important not only for the regulatory mechanism of AT,-R gene transcription, but also for the understanding of anti-atherogenic property of NO.
